Alivus Life Sciences Ltd Share Price
As on 13 June 2026 at 01:08 IST
The Current prices are delayed, log in for live prices
LOGINOver 1 Month
-9.66%
Over 6 Months
15.41%
Over 1 Year
-0.86%
Over 3 Years
66.43%
Alivus Life Sciences Ltd Summary
Close ₹1,017.20
Open ₹1,031.40
High ₹1,047
Low ₹1,009
Volume 88,586
Net Turnover (in Cr) ₹9.1
52Wk High ₹1,148.40
52Wk Low ₹819
52Wk High / Low
819
1,148.40
Alivus Life Sciences Ltd Fundamentals
Key Financial Data
Market Cap (in Cr) ₹12,485.06
EPS (TTM) 47.56
Book Value (BV) 271.48
Div. Yield 0.49 %
P/E (TTM) 22.22
Price/Book Value 3.76
Delivery % 49.29 %
Face Value 2
Key Ratios
PE Ratio 27.24
PB Ratio 4.70
EV to Sales 5.54
PEG Ratio 8.72
ROA 16.79
ROE 18.86
Debt-Equity 0.01
Net Profit Margin 20.35
Operating Profit Margin 30.05
Alivus Life Sciences Ltd Financials
Profit and Loss
No data available
Balance Sheet
No data available
Cash Flow
No data available
Profit and Loss
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Total Revenue | 2,421.45 | 2,295.26 | 2,190.18 | 2,137.92 | 1,885.98 |
| Total Expenses | 1,767.32 | 1,663.97 | 1,561.57 | 1,572.99 | 1,415.03 |
| Profit Before Tax | 654.13 | 631.29 | 628.61 | 564.92 | 470.94 |
| Profit After Tax | 485.63 | 470.89 | 466.96 | 418.72 | 351.58 |
| Operating Profit After Depreciation | 656.54 | 632.84 | 629.16 | 592.89 | 558.49 |
Balance Sheet
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Fixed Assets | 962.61 | 809.87 | 792.89 | 595.03 | 572.80 |
| Total Non Current Assets | 1,076.30 | 934.41 | 851.81 | 706.42 | 598.03 |
| Total Current Assets | 2,335.16 | 1,916 | 1,850.34 | 1,764.58 | 1,399.04 |
| Total Assets | 3,411.45 | 2,850.41 | 2,702.15 | 2,471.01 | 1,997.08 |
| Total Shareholder's Fund | 2,817.37 | 2,332.32 | 2,138.21 | 2,054.31 | 752.75 |
Cash Flow
| Particulars (in ₹ Cr.) | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Net Cash From Operating Activities | 391.52 | 413.52 | 306.01 | 597.59 | 388.11 |
| Net Cash Used In Investing Activities | -615.65 | -116.48 | -146.75 | -122.23 | -68.73 |
| Net Cash Used In Financing Activities | -6.23 | -279.44 | -387.59 | -78.80 | -213.78 |
No data available
| Particulars (in ₹ Cr.) | 2026-03 | 2025-12 | 2025-09 | 2025-06 | 2025-03 |
|---|---|---|---|---|---|
| Total Revenue | 689.12 | 672.89 | 587.98 | 601.85 | 649.55 |
| Total Expenses | 474.59 | 441.61 | 408.81 | 429.54 | 451.11 |
| Profit Before Tax | 215.80 | 198.40 | 174.13 | 162.99 | 191.30 |
| Profit After Tax | 162.66 | 150.26 | 130.03 | 121.54 | 141.87 |
| Operating Profit after Depreciation | 237.31 | 245.21 | 193.89 | 181.30 | 208.53 |
Alivus Life Sciences Ltd Technicals
Support and Resistance
S3 S2 S1 Pivot R1 R2 R3
S1 1,001.80
S2 986.40
S3 963.80
Pivot 1,024.40
R1 1,039.80
R2 1,062.40
R3 1,077.80
Moving Average
20 SMA 1,046.79
50 SMA 1,050.36
100 SMA 984.18
200 SMA 952.79
Alivus Life Sciences Ltd Corporate Actions
Alivus Life Sciences Ltd
₹5.0/Share
Announcement Date 01 Sep 2025
Record Date 01 Sep 2025
Div Yield 250%
Alivus Life Sciences Ltd Peer Comparison
| Company | Price | Market Cap (in Cr) |
|---|---|---|
| Sun Pharmaceutical Industries Ltd | ₹1,794.30 | ₹4,30,512.67 |
| Divis Laboratories Ltd | ₹6,651.25 | ₹1,76,569.79 |
| Torrent Pharmaceuticals Ltd | ₹4,570 | ₹1,54,669.57 |
| Cipla Ltd | ₹1,383 | ₹1,11,725.01 |
| Zydus Lifesciences Ltd | ₹1,105.65 | ₹1,11,254.26 |
Alivus Life Sciences Ltd Top Mutal Funds Invested
| Fund Name | AUM |
|---|---|
| Quant Healthcare Fund | 6.98% |
| Old Bridge Focused Fund | 4.15% |
| Quantum Small Cap Fund | 2.32% |
| ICICI Pru P.H.D Fund | 1.77% |
| Quant Flexi Cap Fund | 1.64% |
Alivus Life Sciences Ltd News
Alivus Life Sciences rises after Q4 PAT climbs 15% YoY to Rs 163 cr
Alivus Life Sciences rose 1.15% to Rs 1,056.85 after the company reported 14.66% jump in standalone net profit to Rs 162.66 crore on 6.09% increase in revenue from operations to Rs 689.11 crore in Q4 FY26 over Q4 FY25.
18 May 2026, 12:05 pm
Alivus Life Sciences Q4 PAT climbs 15% YoY to Rs 163 cr
Alivus Life Sciences reported 14.66% jump in standalone net profit to Rs 162.66 crore on 6.09% increase in revenue from operations to Rs 689.11 crore in Q4 FY26 over Q4 FY25.
16 May 2026, 10:07 am
Board of Alivus Life Sciences recommends final dividend
Of Rs 5 per share
15 May 2026, 11:14 am
Alivus Life Sciences to declare Quarterly Results
On 14 May 2026
08 May 2026, 12:02 pm
Alivus Life Sciences allots 55,000 equity shares under ESOS
22 Jan 2026, 10:47 am
Alivus Life Sciences Ltd Stock Analysis
- Annual revenue for Alivus Life Sciences Ltd increased by 5.50% to ₹2,421.45 crore in FY 2025 from ₹2,295.26 crore in FY 2024.
- Annual Net Profit for Alivus Life Sciences Ltd increased by 3.13% to ₹485.63 crore in FY 2025 from ₹470.89 crore in FY 2024.
- Promoter Shareholding in Alivus Life Sciences Ltd decreased by 0.04% in the most recent quarter, from 74.91% in December 2025 to 74.87% in March 2026.
- Alivus Life Sciences Ltd delivered a 1-year return of -0.86% compared to the Nifty 50, which provided a return of -7.87% as of the last trading session.
- Alivus Life Sciences Ltd share price moved up by 1.75% from its previous close of INR ₹1,017.20. The latest Alivus Life Sciences Ltd share price is INR ₹1,035.
- Alivus Life Sciences Ltd share price today has been at a low of 1,028.50 and a high of 1,045. Over the past 52 weeks, the Alivus Life Sciences Ltd share price has seen a low of 819 and a high of 1,148.40.
FAQ’s
What is the share price of Alivus Life Sciences Ltd today?
Alivus Life Sciences Ltd share price as on 12 Jun 2026 is ₹ 1035.0
What is the Market Cap of Alivus Life Sciences Ltd?
The market cap of Alivus Life Sciences Ltd stock is ₹12,485.06 Cr.
What is the PE Ratio of Alivus Life Sciences Ltd?
The Price to Earnings (P/E) Ratio of Alivus Life Sciences Ltd is 27.24
What is the PB Ratio of Alivus Life Sciences Ltd?
The Price to Book (P/B) Ratio of Alivus Life Sciences Ltd is 4.70
What is the 52 week high of Alivus Life Sciences Ltd Share Price?
The 52 week high of Alivus Life Sciences Ltd share price stands at ₹1,148.40
What is the 52 week low of Alivus Life Sciences Ltd Share Price?
The 52 week low of Alivus Life Sciences Ltd share price stands at ₹819
How can I buy shares of Alivus Life Sciences Ltd?
Simply open a demat account with Torus Digital and place an order to buy shares of Alivus Life Sciences Ltd.
Open FREE
3-in-1 Account
for all your banking, trading and demat needs
Trade in stocks,
derivatives and F&O
